TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean time for debridement of root canals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Canal transportation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective sleepiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG markers of sleep homeostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of pulmonary, renal, or hepatic failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lactate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Superficial blood flow (sBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Composite of death/congestive heart failure/cardiogenic shock/myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Mean body mass loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total fluid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calculated sweat rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health status improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Angina relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: higher order aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gingival bleeding score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral health behaviour of children
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: oral health knowledge and attitudes of mothers and teachers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median Phe concentrations over 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of time blood Phe in target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Atelectasis size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Peak concentrations of IL-1beta, TNFalpha, and IL-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: collagen fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of model-P
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved recognition of cancer symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women with low osteopontin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of red blood cell transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Donor exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 1-year amputation-free survival (AFS)
Endpoint domain: Mortality/survival
Primary endpoint: Episodic recognition performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of time spent in the international normalized ratio range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health utilities of cancer scenarios
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in psychosocial acceptance of asthma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: lung cancer incidence
Endpoint domain: Mortality/survival
Primary endpoint: Support for the development and use of SCPs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinician CGI-S
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Teacher social competence ratings (SCS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Sensitivity of 1-hour postprandial plasma glucose screening test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Specificity of 1-hour postprandial plasma glucose screening test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: number of patients infected
Endpoint domain: Adverse events/effects
Primary endpoint: number of infections
Endpoint domain: Adverse events/effects
Primary endpoint: number of deaths
Endpoint domain: Mortality/survival
Primary endpoint: complete occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between 25-VD3 and RANTES
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Correlation between 25-VD3 and bFGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average compliance with occlusion therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of IgA and IgG antibodies to cow's milk and casein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: years-needed-to-treat (YNT) to add 1 year of life
Endpoint domain: Mortality/survival
Primary endpoint: average total years of life for carvedilol vs. metoprolol
Endpoint domain: Mortality/survival
Primary endpoint: Adequate clinical and parasitological response (ACPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tracheal pain at 24 hours after extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: facial symmetry improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year progression-free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: 1-year overall survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: SCORAD score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of peritonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Episodes of ESI
Endpoint domain: Adverse events/effects
Primary endpoint: Survival advantage for vaccinated patients
Endpoint domain: Mortality/survival
Primary endpoint: onset of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: onset of motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: duration of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: duration of motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Support for self-management of low back pain (LBP)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cmax,ss values for Clzapine and Clozaril
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0‐12 values for Clzapine and Clozaril
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular events rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: body weight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: intra-abdominal fat area reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subthreshold depressive disorder improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QOLIE‐31 Total scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: sensitivity to detect aneuploidy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in clinician sun protection counseling activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Test turnaround time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED clinical decision times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overweight risk (BMI for age: 85th to < 95th percentile)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weight gain during olanzapine treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mask ventilation difficulty score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of difficult mask ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DTH response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PBMC proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma levels of alpha-tocopherol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased writing size (diminished micrographia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DCE MR imaging enhancement fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Volume transfer constant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Integrated area under the contrast agent uptake curve at 60 seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Range of motion improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Appearance improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Muscle strength increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vo(2)peak increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in shoulder pain (WUSPI scores)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Survival (S)
Endpoint domain: Mortality/survival
Primary endpoint: anxiety reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: discomfort reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: decreased treatment time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-Related Quality of Life (HRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Device-related adverse events (AEs) rate
Endpoint domain: Adverse events/effects
Primary endpoint: Surgical intervention rate
Endpoint domain: Adverse events/effects
Primary endpoint: HRQL questionnaire completion rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of EPEC infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Duration of ETEC infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Duration of G. lamblia infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of mitotic cells in the top half of the colonic crypt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tolerability of mifepristone compared to Yuzpe regimen
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of recurrent bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sRANKL change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: OC change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: OPG change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: median absolute rotation of IOLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective cognitive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: subjective executive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Delay in obtaining medical review
Endpoint domain: Adverse events/effects
Primary endpoint: Nonadherence with inhaled corticosteroid therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total effective rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: blood flow recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of responders according to EULAR response criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in FMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Occurrence of pulpitis
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of fracture
Endpoint domain: Adverse events/effects
Primary endpoint: cost-effectiveness ratio
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sensitivity of CV + IVUS for detecting venous anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Specificity of CV + IVUS for detecting venous anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: stone expulsion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expulsion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean analgesic dosage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Satisfaction with quality of health services
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: glucose tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vitality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Everyday living ability
Endpoint domain: Life impact
Endpoint subdomain: Functional status
Primary endpoint: Size of residual CSHs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of CSH recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: average time to complete healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average time NPWT was applied
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of HIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of HSV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: ad libitum energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infection
Endpoint domain: Adverse events/effects
Primary endpoint: hepatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of newly formed bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative probability of failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of reoperation for glaucoma
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Life (QoL) improvements
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: lumen gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neointimal proliferation
Endpoint domain: Adverse events/effects
Primary endpoint: EC50 of loss of responsiveness to verbal command
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of hypnosis measured by Bispectral Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of hypnosis measured by Narcotrend Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of hypnosis measured by cAAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug-related problems identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Arterial Pressure (MAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional Well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Social Functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Delayed colonization on the tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduced colonization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Lower maximal bacterial burden in tracheal aspirates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to syncope or pre‐syncopal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressure changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BMI increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to achieve METs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tolerance of the procedure
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Parent-Reported Composite Risk Scores for cognitive health
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean effective dose (ED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual analog pain-scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Percent fat absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent calcium absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: tumor viability assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Dislodgement rate between 2MCL and 5AAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median displacement between 2MCL and 5AAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Minor lung injuries at the 5AAL position
Endpoint domain: Adverse events/effects
Primary endpoint: time to first P. vivax infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first clinical episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of having at least one clinical P. vivax episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment response to pharmacotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fecal incontinence quality-of-life scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: C-reactive protein changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood sedimentation changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: mean number of lymph nodes retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Risk of ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Risk of CHD events
Endpoint domain: Mortality/survival
Primary endpoint: Effective antimicrobial therapy for gram-positive soft tissue infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Effective antimicrobial therapy for nosocomial pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Force for flap tensioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with hypoxemia events
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of root canal filling materials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Unmet need for contraception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: health perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: social limitation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: sleep/energy performance
Endpoint domain: Life impact
Endpoint subdomain: Sleep